StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.86−0.09 (-4.85%)

Close on Nov 17, 2026Market cap $33.80MP/E –Yield –

Alterity Therapeutics EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

For fiscal 2025 it was -9.50 AUD. The highest annual figure on record is -9.50 AUD in fiscal 2025.

Annual eps

PeriodPeriod endValueChange
FY2025Jun 30, 2025-9.50 AUD–
FY2024Jun 30, 2024-26.00 AUD–
FY2023Jun 30, 2023-28.50 AUD–
FY2022Jun 30, 2022-26.50 AUD–
FY2021Jun 30, 2021-45.00 AUD–
FY2020Jun 30, 2020-75.00 AUD–
FY2019Jun 30, 2019-100.00 AUD–
FY2018Jun 30, 2018-77.50 AUD–
FY2017Jun 30, 2017-70.50 AUD–
FY2016Jun 30, 2016-72.50 AUD–

More Alterity Therapeutics figures

See a number that looks wrong?